Zygote Intra-Fallopian Transfer (ZIFT) — Procedure Guide, Recovery & Risks | MyMedicPlus

Zygote intra-fallopian transfer (ZIFT) is an assisted reproductive technology (ART) that combines standard in vitro fertilisation (IVF) laboratory fertilisation with surgical intrafallopian transfer of confirmed Day 1 zygotes — fertilised eggs showing two distinct pronuclei indicating successful fertilisation — directly into the fallopian tube via laparoscopy, allowing early embryo transport through the natural fallopian tube environment to the uterus for implantation. ZIFT bridges two earlier ART approaches: GIFT (gamete intra-fallopian transfer, where unfertilised eggs and sperm are transferred without prior fertilisation confirmation), and conventional IVF (where embryos are cultured to Day 3 or Day 5 blastocyst stage before transcervical uterine transfer without laparoscopy). The physiological rationale for ZIFT is that early embryo transport through the fallopian tube — where the embryo normally travels after fertilisation in natural conception — may provide a more favourable molecular signalling environment than direct uterine culture to blastocyst. However, ZIFT requires two separate general anaesthetic procedures: one for egg retrieval and a second laparoscopy 24 hours later for zygote transfer, making it more complex and invasive than standard IVF. ZIFT is distinguished from GIFT (gamete intra-fallopian transfer) by the critical advantage that fertilisation is confirmed in the laboratory before transfer, ensuring only viable zygotes are introduced into the fallopian tube.

ZIFT is indicated for couples with infertility where at least one fallopian tube is confirmed patent and healthy — assessed by hysterosalpingography (HSG) or diagnostic laparoscopy — and where standard IVF with intrauterine embryo transfer has failed in previous cycles despite good-quality embryos. Additional indications include severe male factor infertility where successful in vitro fertilisation has been achieved, unexplained infertility after failed IVF, and situations where the clinical team believes embryo development in a physiological fallopian tube environment may improve implantation rates over laboratory culture. Absolute contraindications include bilateral tubal occlusion or absence of both fallopian tubes, as the procedure requires an intact tube for embryo transport. Couples must understand they are accepting additional surgical risk from the laparoscopy and second general anaesthetic compared with standard IVF. Because ZIFT requires two procedures within 24–48 hours and provides no clear advantage over blastocyst transfer in most published comparisons, it has largely been replaced by IVF with Day 5 blastocyst transfer at most modern fertility centres.

The ZIFT cycle begins identically to a standard IVF cycle. The female partner undergoes controlled ovarian hyperstimulation with gonadotrophins (FSH with or without LH) over approximately 10–14 days, monitored by serial transvaginal ultrasound follicle tracking and serum oestradiol measurements. When leading follicles reach 17–20 mm diameter, ovulation is triggered with human chorionic gonadotrophin (hCG) or GnRH agonist. Transvaginal ultrasound-guided oocyte retrieval is performed 36 hours after trigger under intravenous sedation and local anaesthesia, typically yielding 8–15 mature oocytes in a stimulated cycle. The retrieved eggs are inseminated with prepared sperm either by standard insemination (for normal semen parameters) or intracytoplasmic sperm injection (ICSI) in the IVF laboratory. Fertilisation is confirmed at 16–18 hours post-insemination when each egg is examined for the presence of two distinct pronuclei (2PN) — the zygote stage. On Day 1 (approximately 24 hours after egg retrieval), laparoscopy is performed under general anaesthesia. Up to 4 confirmed zygotes are drawn into a transfer catheter and injected into the ampullary segment of one or both fallopian tubes through the fimbrial end under laparoscopic vision. The laparoscopy takes 20–30 minutes and the patient is discharged the same day. The laparoscopic procedure takes approximately 30-45 minutes; the patient recovers for 2-4 hours post-operatively before discharge on the same day with analgesics for peritoneal gas discomfort.

ZIFT offers a documented fertilisation status advantage over GIFT by ensuring only confirmed 2PN zygotes are transferred — eliminating transfer of unfertilised oocytes or abnormally fertilised 3PN eggs. Clinical pregnancy rates of 25–30% per initiated cycle have been reported, broadly comparable to conventional IVF with Day 3 embryo transfer in published series from specialist centres. In selected patients with repeated IVF failure of good-quality embryos, ZIFT may offer an alternative approach through fallopian tube exposure. For couples and clinicians who prefer earliest possible physiological embryo transfer before the blastocyst stage, ZIFT provides a theoretically more natural developmental environment during the critical early cleavage divisions. Laboratory and handling requirements for ZIFT are simpler than for extended blastocyst culture, which historically required specialised embryology systems — an advantage that has diminished as IVF laboratory technology has improved universally.

ZIFT carries all the risks of standard IVF (ovarian hyperstimulation syndrome from ovarian stimulation in 1–5% of cycles, multiple pregnancy if multiple zygotes implant, failed fertilisation requiring cycle cancellation) plus the additional risks of laparoscopy and general anaesthesia. Laparoscopic risks include bowel, bladder, or vascular injury (less than 0.5% at experienced centres), post-operative shoulder tip pain from CO2 gas distension, wound infection, and adhesion formation from peritoneal trauma. Ectopic pregnancy risk is elevated compared with standard IVF uterine embryo transfer because zygotes are placed in the fallopian tube — a proportion may implant within the tube rather than migrating successfully to the uterus, especially in tubes with subclinical functional impairment. Post-operative nausea, abdominal bloating, and discomfort from the laparoscopy last 24–72 hours. The requirement for two separate procedures, two anaesthetics, and two recovery periods within 24 hours represents a significant physical and logistical burden on patients.

Following the laparoscopic ZIFT procedure, patients rest for 2–4 hours before discharge. Mild abdominal discomfort, bloating from residual CO2 gas, and shoulder tip pain from diaphragmatic irritation are expected and resolve within 24–72 hours. Analgesics (paracetamol, ibuprofen) manage post-laparoscopic pain. Strenuous physical activity and sexual intercourse are restricted for 5–7 days. Luteal phase support — progesterone pessaries, gel, or injections — is commenced on the evening of the egg retrieval and continued until the pregnancy test and beyond in the event of a positive result. Progesterone supplementation compensates for the hormonal deficit resulting from the stimulated cycle and exogenous trigger. A serum beta-hCG pregnancy test is performed exactly 14 days after egg retrieval. If positive, an early viability ultrasound scan is arranged at 6–7 weeks gestation to confirm intrauterine location and foetal cardiac activity, and to exclude ectopic pregnancy. If the cycle is unsuccessful, counselling about next steps — including conventional IVF with blastocyst transfer as an alternative — is offered.